share_log

Biodexa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)

SEC announcement ·  Feb 15 04:37
Summary by Futu AI
Biodexa Pharmaceuticals, previously known as Midatech Pharma PLC, filed an amendment to a Schedule 13G with the Securities and Exchange Commission on December 31, 2023. The filing was made by CVI Investments, Inc., with Heights Capital Management, Inc. acting as the investment manager, both of which disclaimed beneficial ownership of the shares except for their pecuniary interest. The amendment indicates that CVI Investments, Inc. and Heights Capital Management, Inc. no longer hold more than five percent of Biodexa Pharmaceuticals' ordinary shares, which have a nominal value of £0.001 per share. The filing was completed on February 12, 2024, and includes a certification that the shares were not acquired for the purpose of changing or influencing the control of the issuer.
Biodexa Pharmaceuticals, previously known as Midatech Pharma PLC, filed an amendment to a Schedule 13G with the Securities and Exchange Commission on December 31, 2023. The filing was made by CVI Investments, Inc., with Heights Capital Management, Inc. acting as the investment manager, both of which disclaimed beneficial ownership of the shares except for their pecuniary interest. The amendment indicates that CVI Investments, Inc. and Heights Capital Management, Inc. no longer hold more than five percent of Biodexa Pharmaceuticals' ordinary shares, which have a nominal value of £0.001 per share. The filing was completed on February 12, 2024, and includes a certification that the shares were not acquired for the purpose of changing or influencing the control of the issuer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.